| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/31/2007 | CN1903242A Total saponin of American ginseng and injection liquid thereof |
| 01/31/2007 | CN1903240A Medicinal use of Aralia continentalis kitag |
| 01/31/2007 | CN1903238A Extractive of traditional Chinese medicine, its prepns., preparing method and application thereof |
| 01/31/2007 | CN1903235A Novel process for preparing scabish oil |
| 01/31/2007 | CN1903231A Ginkgo tree leave tincture |
| 01/31/2007 | CN1903229A Ultrasonic process for extracting pine needle total flavone |
| 01/31/2007 | CN1903221A Dispersion tablets of Naoxueking for treating cerebrovascular disease and its prepn. method |
| 01/31/2007 | CN1903206A Alprostadil freeze-dried emulsion and its prepn. method |
| 01/31/2007 | CN1903204A Methionine vitamin B1 for injection and its prepn. method |
| 01/31/2007 | CN1903189A Medicine composition contg. Tamsulosin and calcium antagonist |
| 01/31/2007 | CN1903177A Alprostadil nano-particles and its prepn. method |
| 01/31/2007 | CN1903173A Nimodipine nanometer granule and its prepn. method |
| 01/31/2007 | CN1297558C 4-oxo-4,6,7,8-tetrahydro-pyrrolo[1,2-a]pyrazine-6-carboxamide compounds, preparation method thereof and pharmaceutical composition containing them |
| 01/31/2007 | CN1297555C Antagonists of MCP-q function and method of use thereof |
| 01/31/2007 | CN1297548C Cyclic hemiacetal derivative and use thereof |
| 01/31/2007 | CN1297546C Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
| 01/31/2007 | CN1297527C Stabilized compositions of aqueous reduced coenzyme Q solution |
| 01/31/2007 | CN1297307C Infusion of gen-seng, lilyturf root and amino acid and its preparing method |
| 01/31/2007 | CN1297296C Quick acting Chinese medicine for dissolving thrombolysis and dredging collaterals and its preparation method |
| 01/31/2007 | CN1297290C Medicinal composition for treating coronary heart disease and stenocardia and its preparation method |
| 01/31/2007 | CN1297288C Medicine for treating cardiovascular disease, and its prepn. method |
| 01/31/2007 | CN1297287C Compound red sage root and amino acid infusion and its preparing method |
| 01/31/2007 | CN1297280C Breviscapine amino acid transfusion liquid and its producing method |
| 01/31/2007 | CN1297279C Medicinal composition containing danshensu, total ara-saponin and camphol and its preparation and use |
| 01/31/2007 | CN1297278C Medicinal composition containing salvianolic acid B, total ara-saponin and camphol and its preparation and use |
| 01/31/2007 | CN1297277C Laminaran granule and its preparation technology |
| 01/31/2007 | CN1297267C Medicinal composition containing tanshinon II A sodium sulfonate and its quality control method |
| 01/31/2007 | CN1297265C Novel association of an antithrombotic agent with aspirin and use thereof for treating atherothrombotic diseases |
| 01/31/2007 | CN1297259C Total diterpene phenol originated from rosemary, its preparation method and use |
| 01/31/2007 | CN1297256C Oral drop pills for treating coronary disease and preparation method thereof |
| 01/30/2007 | US7169951 Quinazoline derivatives and pharmaceutical applications thereof |
| 01/30/2007 | US7169927 Heterocyclic amides or prodrugs used in the treatment of diabetes, insulin resistance, metabolic disorders and obesity |
| 01/30/2007 | US7169924 Pyrimidinone derivatives and their use in the treatment of atherosclerosis |
| 01/30/2007 | US7169921 that bear a N-2-(alkoxycarbonylamino)ethyl substituent; intermediates in the synthesis of 1,3-diaza-6-oxa-adamantanes |
| 01/30/2007 | US7169817 Treatment and/or prevention of diseases or disorders mediated by lymphocyte interactions. |
| 01/30/2007 | US7169810 Phenylalkyleneoxybenzene derivatives; insulin resistance; diabetes, obesity, dyslipidemia treatment; hypotensive agents |
| 01/30/2007 | US7169798 Inhibitors of c-Jun N terminal kinases (JNK) and other protein kinases |
| 01/30/2007 | US7169796 Polyarylcarboxamides useful as lipid lowering agents |
| 01/30/2007 | US7169794 Oxidation of a chemical intermediate |
| 01/30/2007 | US7169790 5-substituted 2-aryl-4-pyrimidinones |
| 01/30/2007 | US7169787 e.g., N-(4-pyridylmethyl)-1-cyclopropylmethyl-7-azaindole-3-carboxylic acid amide |
| 01/30/2007 | US7169782 Aryl substituted thiazolidinones and the use thereof |
| 01/30/2007 | US7169779 Inhibitors of p38 |
| 01/30/2007 | US7169778 Antiproliferative agents; anticancer agents; central nervous system disorders; antiarthritic agents |
| 01/30/2007 | US7169776 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 01/30/2007 | US7169758 Use of hepcidin as a regulator of iron homeostasis |
| 01/30/2007 | US7169594 detecting the presence or absence of increased S6 kinase activity in said biological sample. |
| 01/30/2007 | US7169565 Isolated antibody that specifically binds to a polypeptide encoded by polynucleotides composed of any polyribonucleotide or polydeoxribonucleotide, which may be unmodified RNA or DNA or modified RNA or DNA |
| 01/30/2007 | US7169412 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells |
| 01/30/2007 | US7169390 Administering an agent binds a sphingolipid or a sphingolipid metabolite, especially an antibody or derivative, a receptor of a sphingolipid or a sphingolipid metabolite. |
| 01/30/2007 | US7169389 Human CD154 binding molecules and treatment methods |
| 01/30/2007 | US7168597 Aerosol metering valve |
| 01/30/2007 | CA2394861C N6 heterocyclic 8-modified adenosine derivatives |
| 01/30/2007 | CA2163747C Novel 1-phenylalkanone 5-ht4 receptor ligands |
| 01/25/2007 | WO2007011757A1 Use of inhibitors of the ubiquitin proteasome pathway for increasing contractility of the heart |
| 01/25/2007 | WO2007011721A1 Inhibitors of mitotic kinesin |
| 01/25/2007 | WO2007011056A1 Pyrazole compounds and thrombopoietin receptor activators |
| 01/25/2007 | WO2007010965A1 Azaindole derivative having pgd2 receptor antagonistic activity |
| 01/25/2007 | WO2007010858A1 Pluripotent stem cell cloned from single cell derived from skeletal muscle tissue |
| 01/25/2007 | WO2007010501A2 A pharmaceutical composition comprising a combination of beta blocker and an ace inhibitor |
| 01/25/2007 | WO2007010390A1 Indazolecarboxamide derivatives as 5ht4 receptor agonists |
| 01/25/2007 | WO2007010383A1 Novel heterocyclidene acetamide derivative |
| 01/25/2007 | WO2007010337A2 Use of phosphodiesterase type 5 inhibitors for the prevention and treatment of diseases or health disorders and dispensing system for said inhibitors |
| 01/25/2007 | WO2007010312A2 Use of mmp inhibitors for the preparation of pharmaceutical compositions of cardioprotective effect |
| 01/25/2007 | WO2007010216A1 Lycopene formulations for the treatment of atherosclerotic conditions |
| 01/25/2007 | WO2007009670A1 4-chromenonyl-1,4-dihydropyridinecarbonitriles and the use thereof |
| 01/25/2007 | WO2007009404A1 Rh-epo nasal formulations with low sialic acid concentration for the treatment of diseases of the central nervous system |
| 01/25/2007 | WO2007009395A1 Schisandrin b preparation |
| 01/25/2007 | WO2007009359A1 Thymosin beta 4 derivatives and use thereof |
| 01/25/2007 | WO2007009194A1 Sra binding protein |
| 01/25/2007 | WO2007009187A1 Polyphenol and probiotic containing nutritional supplement |
| 01/25/2007 | WO2007009146A1 Substituted 1-phenyl imidazoles as cox-i inhibitors |
| 01/25/2007 | WO2006126082A3 Pyridine [3,4-b] pyrazinones as pde-5 inhibitors |
| 01/25/2007 | WO2006122254A3 Stable micronized candesartan cilexetil and methods for preparing thereof |
| 01/25/2007 | WO2006121861A3 Biphenylazetidinone cholesterol absorption inhibitors |
| 01/25/2007 | WO2006114439A3 Novel nutraceutical compositions |
| 01/25/2007 | WO2006113864A3 Oxindole compounds and their uses as therapeutic agents |
| 01/25/2007 | WO2006105219A3 T cell therapy for the treatment of cachexia and chronic diseases |
| 01/25/2007 | WO2006085144A3 Compositions containing high omega-3 and low saturated fatty acid levels |
| 01/25/2007 | WO2006050921A3 Preparation of telmisartan salts with improved solubility |
| 01/25/2007 | WO2005123128A3 Methods for treating conditions associated with masp-2 dependent complement activation |
| 01/25/2007 | US20070021593 for use in the treatment of inflammation and ischemia-reperfusion injury |
| 01/25/2007 | US20070021494 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 01/25/2007 | US20070021491 Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events |
| 01/25/2007 | US20070021483 Amidine derivatives for treating amyloidosis |
| 01/25/2007 | US20070021476 Neuroprotectants; treatment of neuropathies resulting from chemtherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases; neurodegenerative diseases; enzyme inhibitors for seine/threonine kinases, phosphatases; Alzheimer' |
| 01/25/2007 | US20070021464 Methods and compositions for inhibition of angiogenesis with EM-12 Derivatives |
| 01/25/2007 | US20070021440 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 01/25/2007 | US20070021420 New derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments |
| 01/25/2007 | US20070021418 Method of inhibiting production of osteopontin |
| 01/25/2007 | US20070021416 Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides |
| 01/25/2007 | US20070021394 2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic ester derivative |
| 01/25/2007 | US20070021386 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
| 01/25/2007 | US20070021375 Genetic modification of targeted regions of the cardiac conduction system |
| 01/25/2007 | US20070021335 Agent for improving mental disorders |
| 01/25/2007 | US20070021321 determining whether catechin or an antibody has the same pharmacological effect as that of epigallocatechin gallate, on inhibiting cell proliferation, angiogenesis or cancer cell metastasis, as a neuroprotectant, a viricide, an antiallergen and as a antiarteriosclerotic agent |
| 01/25/2007 | US20070020306 Endovascular implant with an at least sectional active coating made of radjadone and/or a ratjadone derivative |
| 01/25/2007 | US20070020271 Endothelial cell specific antibodies and uses thereof |
| 01/25/2007 | US20070020265 administering non-blocking anti-CD20 antibody and carrier; fusion proteins; rheumatoid arthritis |
| 01/25/2007 | US20070020260 Glycoprotein compositions |